Dr Reddys Laboratories RDY
NYSE RDY
$12.85 +0.34 (+2.68%)
As of: Sep 29, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Receivables - Net (2009 - 2026)

Updated

Dr Reddys Laboratories' Receivables - Net was $1.06 billion in the quarter ended Jun 30, 2026, down 4.5% from $1.11 billion a year earlier and down 4.1% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Receivables - Net (2009 - 2026) Analysis & Trends

As of Mar 31, 2026, Receivables - Net at Dr Reddys Laboratories came in at $1.08 billion, up 2.0% from the prior year.

  • Receivables - Net has now increased for seven consecutive years, with a five-year compound annual growth rate of 9.7% (years ended Mar 2021 to Mar 2026).
  • In earlier years, Receivables - Net was $1.06 billion in the year ended Mar 31, 2025 (+9.9%), $963 million in the year ended Mar 31, 2024 (+9.1%), $883 million in the year ended Mar 31, 2023 (+0.3%) and $880 million in the year ended Mar 31, 2022 (+29.6%).
  • The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Receivables - Net since the quarter ended Mar 31, 2025.
  • Compared with a year earlier, Receivables - Net was higher in seven of the last eight quarters, with growth averaging 9.6%.
  • The best year-over-year quarter for Receivables - Net over five years was the quarter ended Sep 30, 2021 (growth of 34.5%); the worst was the quarter ended Sep 30, 2023 (a decline of 12.7%).
  • Per Business Quant data, RDY's Receivables - Net in the three quarters before the quarter ended Jun 30, 2026 was $1.11 billion (quarter ended Mar 31, 2026), $1.16 billion (quarter ended Dec 31, 2025) and $1.12 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Dr Reddys Laboratories 10.44 Bn 9.62 Bn 396.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.06 Bn
Mar 31, 2026 1.11 Bn
Dec 31, 2025 1.16 Bn
Sep 30, 2025 1.12 Bn
Jun 30, 2025 1.11 Bn
Mar 31, 2025 1.04 Bn
Dec 31, 2024 1.09 Bn
Sep 30, 2024 1.01 Bn
Jun 30, 2024 972.06 Mn
Mar 31, 2024 966.91 Mn
Dec 31, 2023 941.78 Mn
Sep 30, 2023 843.43 Mn
Jun 30, 2023 939.00 Mn
Mar 31, 2023 881.77 Mn
Dec 31, 2022 914.05 Mn
Sep 30, 2022 965.63 Mn
Jun 30, 2022 893.00 Mn
Mar 31, 2022 888.62 Mn
Dec 31, 2021 834.26 Mn
Sep 30, 2021 926.73 Mn
API Access

Dr Reddys Laboratories Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=RDY&period=max&api_key=YOUR_API_KEY